Related Experiment Videos
Cerebral amyloid angiopathies
Insights
Cerebral amyloid angiopathies involve amyloid deposition in brain blood vessels, causing strokes. Genetic mutations in hereditary forms are identified, aiding diagnosis, but causes of the common sporadic form remain unknown.
Area of Science:
- Neurology
- Vascular Biology
- Genetics
Background:
- Cerebral amyloid angiopathies (CAAs) are a diverse group of disorders.
- Characterized by amyloid deposition in cerebral blood vessels, leading to strokes.
- Two main forms exist: Cystatin C CAA and beta-amyloid CAA.
Purpose of the Study:
- To distinguish between different forms of cerebral amyloid angiopathies.
- To understand the genetic basis and pathogenic mechanisms of CAAs.
- To explore the aetiopathogenesis of sporadic CAA.
Main Methods:
- Histological analysis of amyloid deposition in blood vessels.
- Molecular composition analysis to differentiate CAA types.
- Genetic analysis of precursor protein genes in hereditary CAAs.
Main Results:
- Cystatin C CAA is a rare, autosomal dominant disorder.
- Beta-amyloid CAAs share features with Alzheimer's disease and can be hereditary or sporadic.
- Mutations in precursor protein genes are identified in hereditary CAAs.
- Amyloid deposition leads to vascular degeneration and rupture.
Conclusions:
- Understanding hereditary CAA mutations improves diagnosis.
- The aetiopathogenesis of the common sporadic CAA remains elusive.
- Further research is needed to uncover the causes of sporadic CAA.
Abstract:
The cerebral amyloid angiopathies comprise a heterogeneous group of disorders that are characterized clinically by ischaemic and/or haemorrhagic strokes, and histologically by deposition of amyloid in the wall of leptomeningeal and cerebral cortical blood vessels. On the basis of the molecular composition of the amyloid, two forms can be distinguished. Cystatin C amyloid angiopathy is a rare autosomal dominant disorder confined to several families from Iceland. beta-amyloid cerebral amyloid angiopathies may be hereditary or sporadic, and share clinical, pathological and biochemical features with Alzheimer's disease. Both types of vascular amyloid derive from precursor proteins synthesized in situ by astrocytes (cystatin C) or smooth muscle cells (beta-amyloid), and induce progressive degeneration of smooth muscle cells, blood vessel rupture and haemodynamic changes. In recent years, it has been reported that mutations underlying both types of hereditary cerebral amyloid angiopathy directly involve the gene encoding the precursor protein. These findings have increased our understanding of the amyloidogenic mechanisms and allowed preclinical diagnosis. Nevertheless, the aetiopathogenetic factors involved in the more frequent sporadic form of amyloid angiopathy remain unknown.